Abstract :
Peptides and peptidomimetics demonstrate a notable efficacy paired with the ability to engage targets deemed inaccessible by conventional small molecule drugs. The broad adoption of peptides as viable drug candidates will require collaborative efforts between small molecule groups and those that work near exclusively in the fields of peptide and protein synthesis.